Stocks News

LAST PRICE
16.8600
TODAY'S CHANGE (%)
Trending Down-1.6400 (-8.8649%)

Bid / Lots
17.0000/ 2
Ask / Lots
18.5000/ 3
Open / Previous Close
18.9500 / 18.5000
Day Range
Low 16.7900
High 19.0450
52 Week Range
Low 6.0650
High 19.7100
Volume
1,260,418
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 7, 2024
- Phathom Pharmaceuticals Shares Fall After Q3 Loss Widens, from 10:34AM ET on Thursday Nov 07, 2024 by MT Newswires
  10:34AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PHAT
  10:34 AM EST, 11/07/2024 (MT Newswires) -- Phathom Pharmaceuticals' (PHAT) shares were down 3.3% in recent Thursday trading after the company reported a Q3 net loss of $1.05 per diluted share, wider than a loss of $0.54 a year earlier. Two analysts ...
- -- Earnings Flash (PHAT) PHATHOM PHARMACEUTICALS Posts Q3 Loss $-1.05 Per Share, from 8:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  8:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PHAT
  08:03 AM EST, 11/07/2024 (MT Newswires) -- ...
- *DJ Phathom Pharmaceuticals 3Q Loss/Shr $1.32 >PHAT, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: PHAT
- Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  8:00AM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: PHAT
  expense (A) 0.08 0.11 0.28 0.41 Non-cash interest on revenue interest financing liability 0.18 0.10 0.58 0.33 Interest expense related to amortization of debt discount 0.01 0.01 0.03 0.03 Non-GAAP net loss per share -- basic and diluted ($1.05) ($0.54) ($3.40) ($1.71) ========== ========== ========== ========== Weighted-average shares of common stock outstanding, basic and diluted 64,627,847 56,782,379 60,543,545 49,265,321 (A) Stock-based compensation consists of the following: Three Months Ended Nine Months Ended September 30, September 30, -------------------- ------------------- 2024 2023 2024 2023 Research and development 1,296 1,397 3,876 4,977 Selling, general and administrative 4,339 4,743 13,484 15,464
Nov 4, 2024
- Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: PHAT
  
  Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
  
  FLORHAM PARK, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following investor conferences in November and December:

Nov 8, 2024
- DJ Pliant Therapeutics Price Target Maintained With a $38.00/Share by HC Wainwright & Co., from 12:08PM ET on Friday Nov 08, 2024 by Dow Jones
  12:08PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: PLRX
Nov 7, 2024
- Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: PLRX
- *DJ Pliant Therapeutics 3Q Loss/Shr 95c >PLRX, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: PLRX
Nov 6, 2024
- Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: LQDA
- Pliant Therapeutics to Participate in the Stifel Healthcare Conference, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: PLRX
Nov 4, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA, from 6:16PM ET on Monday Nov 04, 2024 by Dow Jones
  6:16PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: LQDA
- ASP Isotopes Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares, from 4:01PM ET on Monday Nov 04, 2024 by Dow Jones
  4:01PM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: ASPI
- Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  8:00AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: LQDA
Nov 2, 2024
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA, from 11:00AM ET on Saturday Nov 02, 2024 by PR Newswire
  11:00AM ET on Saturday Nov 02, 2024 by PR Newswire
  Companies Mentioned: LQDA
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
  11:00AM ET on Saturday Nov 02, 2024 by Dow Jones
  Companies Mentioned: LQDA

Phathom Pharmaceuticals Inc
NASDAQ:PHATUnited States

Search Criteria

Nov 7, 2024

Phathom Pharmaceuticals Shares Fall After Q3 Loss Widens, from 10:34AM ET on Thursday Nov 07, 2024 by MT Newswires

-- Earnings Flash (PHAT) PHATHOM PHARMACEUTICALS Posts Q3 Loss $-1.05 Per Share, from 8:03AM ET on Thursday Nov 07, 2024 by MT Newswires

*DJ Phathom Pharmaceuticals 3Q Loss/Shr $1.32 >PHAT, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates, from 8:00AM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 4, 2024

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones

Peers Headlines

Nov 8, 2024

DJ Pliant Therapeutics Price Target Maintained With a $38.00/Share by HC Wainwright & Co., from 12:08PM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

*DJ Pliant Therapeutics 3Q Loss/Shr 95c >PLRX, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 6, 2024

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Pliant Therapeutics to Participate in the Stifel Healthcare Conference, from 8:00AM ET on Wednesday Nov 06, 2024 by Dow Jones

Nov 4, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA, from 6:16PM ET on Monday Nov 04, 2024 by Dow Jones

ASP Isotopes Announces Closing of Public Offering and Full Exercise of Underwriter's Option to Purchase Additional Shares, from 4:01PM ET on Monday Nov 04, 2024 by Dow Jones

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024, from 8:00AM ET on Monday Nov 04, 2024 by Dow Jones

Nov 2, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA, from 11:00AM ET on Saturday Nov 02, 2024 by PR Newswire

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Liquidia Corporation - LQDA, from 11:00AM ET on Saturday Nov 02, 2024 by Dow Jones